There will be a record amount of construction completions in the U.S. life science market in 2024, followed by a dramatic drop in 2025, according to CBRE.
In 2024, 21.3 million sf of life science space will be completed in the 13 largest U.S. markets. That’s up from 13.9 million sf last year and 5.6 million sf in 2022.
Much of the projected slowdown is due to a softer economy and reductions in venture capital investment and initial public offerings. Most of the construction scheduled for completion this year, 79%, is in the three largest biotech hubs: Boston, the San Francisco Bay Area, and San Diego.
The potential for a high vacancy rate in those areas is greatest, while supply and demand is expected to remain more balanced in the 10 other primary markets. The average vacancy rate in the 13 markets stood at 10.6% as of the third quarter of 2023.
Related Stories
Laboratories | Sep 26, 2016
Construction has finished on the world’s largest forensic anthropology lab, designed by SmithGroupJJR
The lab’s main purpose will be to help in the investigation, recovery, and accounting of Americans lost in past wars.
Laboratories | Aug 8, 2016
The lab of the future: smaller, flexible, tech-enabled, business focused
A new CBRE report emphasizes the importance of collaboration and standardization in lab design.
Laboratories | Jun 16, 2016
How HOK achieved design consensus for London's Francis Crick Institute
The 980,000-sf, $931 million facility is the result of a unique financing mechanism that brought together three of the U.K.’s heaviest funders of biomedical research—the Medical Research Council, Cancer Research UK, and the Wellcome Trust—and three leading universities—University College London, Imperial College London, and King’s College London.
